Biotech Bay
Filter News
Found 52,172 articles
-
June is Alzheimer’s & Brain Awareness Month and June 21 is dubbed “The Longest Day,” which focuses on raising awareness of Alzheimer’s disease.
-
Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia
6/21/2018
June 21, 2018 20:05 UTC Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia - RT002 Injectable has potential to be first long-acting neuromodulator for treatment of a debilitating involuntary muscle movement disorder - NEWARK, Calif.--( BUSINESS WIRE )-- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in tre
-
Kezar Life Sciences Announces Pricing of Initial Public Offering
6/21/2018
Initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share
-
The U.S. Patent and Trademark Office (USPTO) granted Emmanuelle Charpentier, co-founder of ERS Genomics, the University of California and University of Vienna, their first U.S. patent covering the use of CRISPR/Cas9 for gene editing.
-
Sunny Balwani intends to fight not only the criminal charges, but is also fighting the charges brought by the SEC.
-
The Loncar Cancer Immunotherapy Index has reduced the number of immunotherapy-focused companies from 30 to 25 and also swapped out a number of stocks as part of an effort to strengthen the index’s liquidity profile and ensure the holdings hold equal weight.
-
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform
6/20/2018
The SpeedBird platform is based on TransMed7’s patented Zero5TM work element composed of a fused, single element constructed from 3 hypotubes and forming rotating twin cutter blades.
-
Prellis Biologics Achieves Unprecedented Speed and Resolution in 3D Printing of Human Tissue With Capillaries
6/20/2018
Breakthrough solves a major hurdle in organ and tissue engineering, essential to the goal of eliminating organ transplant waiting list
-
LA BioMed's Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant
6/20/2018
A researcher from LA BioMed has been awarded $688,013 in grant funding from the National Institutes of Health to improve newborn infant screening. The proposal by Rie Sakai-Bizmark, MD, PhD, MPH is entitled "Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation."
-
EPIC's Philip Westphal to Present on Safe Patient Handling at the California Rural Health Conference
6/20/2018
Lecture at the California Rural Health Conference on Wed., June 27 at 11 a.m. at the Lake Natoma Inn in Folsom, CA.
-
Twist Bioscience Expands Executive Team with Industry Veterans
6/20/2018
Appoints James Thorburn as Chief Financial Officer
-
Three years after acquiring a majority stake Foundation Medicine, Pharma giant Roche has agreed to buy up all outstanding shares for about $2.4 billion and bring the company’s sequencing diagnostics platform under the Roche umbrella.
-
Since Allogene Therapeutics launched in April the company has been rapidly expanding its leadership team as it drives forward with a mission of developing allogeneic CAR-T therapies.
-
Bay Labs’ EchoMD AutoEF Software Receives FDA Clearance for Fully Automated AI Echocardiogram Analysis
6/19/2018
Innovative AI Algorithms Automate Both Clip Selection and Ejection Fraction Calculation
-
3Scan and UPMC to Collaborate on a Catalogue of Tissue Information to Enable Discovery in 3D
6/19/2018
3Scan, the world leading 3D tissue data provider and The University of Pittsburgh Medical Center join forces to generate a vast library of tissue data for medical discovery, target identification and therapeutics development
-
ZipLine Medical Closes $9 Million Growth Financing Led by Existing Investor MVM Partners LLP
6/19/2018
ZipStitch, First Non-Invasive, Adjustable Laceration Closure Device Available to Consumers, Wins Medical Design Excellence Award
-
Pharmatech Appoints New Chief Financial Officer
6/19/2018
Pharmatech Associates announces the expansion of its executive management team
-
If convicted Holmes and Balwani face a maximum sentence of 20 years in prison.
-
Biotech companies continue to make moves to strengthen senior leadership teams and drive growth. Here is a roundup of some noted movers and shakers for the week of June 11 - 15.
-
Cytokinetics released data from its Phase II clinical trial of reldesemtiv in patients with spinal muscular atrophy (SMA).